| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |